Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-033011
Filing Date
2023-09-19
Accepted
2023-09-19 12:02:08
Documents
44
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1407083
2 ex-31.htm EX-31 13334
3 ex-32.htm EX-32 4462
  Complete submission text file 0001493152-23-033011.txt   5022364

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clcs-20230630.xsd EX-101.SCH 28516
5 XBRL CALCULATION FILE clcs-20230630_cal.xml EX-101.CAL 34871
6 XBRL DEFINITION FILE clcs-20230630_def.xml EX-101.DEF 184794
7 XBRL LABEL FILE clcs-20230630_lab.xml EX-101.LAB 262910
8 XBRL PRESENTATION FILE clcs-20230630_pre.xml EX-101.PRE 228526
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 711652
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 231262967
SIC: 2834 Pharmaceutical Preparations